Literature DB >> 34836615

Linking altered microRNA expression to racial disparities in uterine serous carcinoma.

Jian-Jun Wei1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34836615      PMCID: PMC9206511          DOI: 10.1016/j.ygyno.2021.11.002

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.304


× No keyword cloud information.
  13 in total

1.  Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study.

Authors:  Mary Kathryn Abel; Cheng-I Liao; Chloe Chan; Danny Lee; Atharva Rohatgi; Kathleen M Darcy; Chunqiao Tian; Amandeep K Mann; George L Maxwell; Daniel S Kapp; John K Chan
Journal:  Gynecol Oncol       Date:  2021-03-13       Impact factor: 5.482

2.  An optimized isolation and labeling platform for accurate microRNA expression profiling.

Authors:  Jaclyn Shingara; Kerri Keiger; Jeffrey Shelton; Walairat Laosinchai-Wolf; Patricia Powers; Richard Conrad; David Brown; Emmanuel Labourier
Journal:  RNA       Date:  2005-07-25       Impact factor: 4.942

3.  Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.

Authors:  Da Yang; Yan Sun; Limei Hu; Hong Zheng; Ping Ji; Chad V Pecot; Yanrui Zhao; Sheila Reynolds; Hanyin Cheng; Rajesha Rupaimoole; David Cogdell; Matti Nykter; Russell Broaddus; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Jinsong Liu; Ilya Shmulevich; Anil K Sood; Kexin Chen; Wei Zhang
Journal:  Cancer Cell       Date:  2013-02-11       Impact factor: 31.743

4.  Pan-cancer clinical and molecular analysis of racial disparities.

Authors:  Olivia D Lara; Ying Wang; Amma Asare; Tao Xu; Hua-Sheng Chiu; Yuexin Liu; Wei Hu; Pavel Sumazin; Shitanshu Uppal; Lin Zhang; J Alejandro Rauh-Hain; Anil K Sood
Journal:  Cancer       Date:  2019-11-15       Impact factor: 6.860

5.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma.

Authors:  Zhaojian Liu; Jinsong Liu; Miguel F Segura; Changshun Shao; Peng Lee; Yaoqin Gong; Eva Hernando; Jian-Jun Wei
Journal:  J Pathol       Date:  2012-04-18       Impact factor: 7.996

7.  MicroRNAs in endometrial cancers from black and white patients.

Authors:  G Larry Maxwell; Yutaka Shoji; Kathleen Darcy; Tracy Litzi; Andrew Berchuck; Chad A Hamilton; Thomas P Conrads; John I Risinger
Journal:  Am J Obstet Gynecol       Date:  2014-08-28       Impact factor: 8.661

8.  Racial disparities in outcomes for high-grade uterine cancer: A California cancer registry study.

Authors:  Mana Baskovic; Daphne Y Lichtensztajn; Trung Nguyen; Amer Karam; Diana P English
Journal:  Cancer Med       Date:  2018-08-19       Impact factor: 4.452

9.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

Review 10.  FBXW7: a critical tumor suppressor of human cancers.

Authors:  Chien-Hung Yeh; Marcia Bellon; Christophe Nicot
Journal:  Mol Cancer       Date:  2018-08-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.